BIOMAT Database Logo BIOMAT Database Logo

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. 1998

J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

The INK4a gene encodes two distinct growth inhibitors--the cyclin-dependent kinase inhibitor p16Ink4a, which is a component of the Rb pathway, and the tumor suppressor p19Arf, which has been functionally linked to p53. Here we show that p19Arf potently suppresses oncogenic transformation in primary cells and that this function is abrogated when p53 is neutralized by viral oncoproteins and dominant-negative mutants but not by the p53 antagonist MDM2. This finding, coupled with the observations that p19Arf and MDM2 physically interact and that p19Rrf blocks MDM2-induced p53 degradation and transactivational silencing, suggests that p19Arf functions mechanistically to prevent MDM2's neutralization of p53. Together, our findings ascribe INK4a's potent tumor suppressor activity to the cooperative actions of its two protein products and their relation to the two central growth control pathways, Rb and p53.

UI MeSH Term Description Entries
D007908 Lens, Crystalline A transparent, biconvex structure of the EYE, enclosed in a capsule and situated behind the IRIS and in front of the vitreous humor (VITREOUS BODY). It is slightly overlapped at its margin by the ciliary processes. Adaptation by the CILIARY BODY is crucial for OCULAR ACCOMMODATION. Eye Lens,Lens, Eye,Crystalline Lens
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D010006 Osteoblasts Bone-forming cells which secrete an EXTRACELLULAR MATRIX. HYDROXYAPATITE crystals are then deposited into the matrix to form bone. Osteoblast
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003856 Deoxyuracil Nucleotides Uracil nucleotides which contain deoxyribose as the sugar moiety. Deoxyuridine Phosphates,Nucleotides, Deoxyuracil,Phosphates, Deoxyuridine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001710 Biotin A water-soluble, enzyme co-factor present in minute amounts in every living cell. It occurs mainly bound to proteins or polypeptides and is abundant in liver, kidney, pancreas, yeast, and milk. Vitamin H,Biodermatin,Biokur,Biotin Gelfert,Biotin Hermes,Biotin-Ratiopharm,Biotine Roche,Deacura,Gabunat,Medebiotin,Medobiotin,Rombellin,Biotin Ratiopharm,Gelfert, Biotin,Hermes, Biotin,Roche, Biotine

Related Publications

J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
The p53 tumor suppressor gene and gene product.
January 1989, Princess Takamatsu symposia,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
MDM2 chaperones the p53 tumor suppressor.
November 2007, The Journal of biological chemistry,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
Pex19p dampens the p19ARF-p53-p21WAF1 tumor suppressor pathway.
June 2001, The Journal of biological chemistry,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
p53-independent apoptosis is induced by the p19ARF tumor suppressor.
July 2002, Biochemical and biophysical research communications,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function.
July 2004, Oncogene,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network.
September 2002, Trends in biochemical sciences,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
October 2003, Oncogene,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
[Alternative protein p19ARF: a genuine tumor suppressor gene].
April 1998, Bulletin du cancer,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
11th Ernst Klenk Lecture. The p53 tumor suppressor gene and product.
April 1993, Biological chemistry Hoppe-Seyler,
J Pomerantz, and N Schreiber-Agus, and N J Liégeois, and A Silverman, and L Alland, and L Chin, and J Potes, and K Chen, and I Orlow, and H W Lee, and C Cordon-Cardo, and R A DePinho
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
November 1997, Cell,
Copied contents to your clipboard!